Jeep’s Toledo Workforce Celebrates 85 Years
🕑4 min read Jeep® celebrated its 85th anniversary Wednesday, at the Toledo Assembly Complex, bringing together Stellantis executives,…
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
First-in-human Phase 1 trial evaluating KT-485 (SAR447971) initiated, triggering a $20 million milestone payment from Sanofi WATERTOWN, Mass.,…